Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Comparison of single and double autologous stem cell transplantation in multiple myeloma patients

Autologous stem cell transplantation (ASCT) is one of the standard treatments of choice for eligible multiple myeloma (MM) patients. Herein, we aimed to analyze MM patients at our center and compare the clinical outcomes of single and double ASCT patients.

Bibliographic Details
Main Authors: Malkan Umit Yavuz, Demiroglu Haluk, Buyukasik Yahya, Karatas Ayse, Aladag Elifcan, Goker Hakan
Format: Article
Language:English
Published: De Gruyter 2021-01-01
Series:Open Medicine
Subjects:
second autologous stem cell transplantation
multiple myeloma
Online Access:https://doi.org/10.1515/med-2021-0216

Similar Items

Similar Items